Healthcare Analysts discuss Alpha-1 Antitrypsin Deficiency (A1ATD) associated lung and liver disease (relevant companies MREO, BEAM, NTLA, VRTX) on an Analyst/Industry conference call to be held on April 26 at 11 am. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MREO:
